Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Sheldon

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of Virology|February 6, 2024
Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Hepatitis C virus cell culture adaptive mutations enhance cell culture propagation by multiple mechanisms but boost antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
Journal of Virology|August 15, 2014
Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virusJulie Sheldon, Nathan M Beach, Elena Moreno, et al.
The Journal of Infectious Diseases|August 21, 2004
Mother-to-child transmission of human herpesvirus-8 in South AfricaMartin Dedicoat, Robert Newton, Khaled R Alkharsah, et al.
Cells|July 2, 2021
Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV InfectivityFrancisco J Zapatero-Belinchón, Rina Ötjengerdes, Julie Sheldon, et al.
Journal of Medical Virology|October 26, 2006
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in SpainCarlos Toro, Victoria Jiménez, Carmen Rodríguez, et al.
AIDS (London, England)|September 22, 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfectionGuenther Schmutz, Mark Nelson, Thomas Lutz, et al.
Science Advances|November 5, 2020
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.
Journal of Clinical Microbiology|June 26, 2016
Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current MethodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Journal of Clinical Microbiology|November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Virology|February 6, 2024
Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Hepatitis C virus cell culture adaptive mutations enhance cell culture propagation by multiple mechanisms but boost antiviral responses in primary human hepatocytesNicola Frericks, Richard J P Brown, Birthe M Reinecke, et al.
Journal of Virology|August 15, 2014
Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virusJulie Sheldon, Nathan M Beach, Elena Moreno, et al.
The Journal of Infectious Diseases|August 21, 2004
Mother-to-child transmission of human herpesvirus-8 in South AfricaMartin Dedicoat, Robert Newton, Khaled R Alkharsah, et al.
Cells|July 2, 2021
Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV InfectivityFrancisco J Zapatero-Belinchón, Rina Ötjengerdes, Julie Sheldon, et al.
Journal of Medical Virology|October 26, 2006
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in SpainCarlos Toro, Victoria Jiménez, Carmen Rodríguez, et al.
AIDS (London, England)|September 22, 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfectionGuenther Schmutz, Mark Nelson, Thomas Lutz, et al.
Science Advances|November 5, 2020
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.
Journal of Clinical Microbiology|June 26, 2016
Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current MethodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Journal of Clinical Microbiology|November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Pageof 6